Lupus Science & Medicine

Long-term outcomes of hydroxychloroquine dose reduction in Puerto Ricans with systemic lupus erythematosus: 6-year follow-up

Background/objective To reduce the risk of hydroxychloroquine (HCQ)-induced retinopathy, the American Academy of ...